{"id":"W4385667424","doi":"10.1097/01.hs9.0000969628.70235.a8","title":"P681: MATCHING-ADJUSTED INDIRECT COMPARISON OF ASCIMINIB VERSUS OTHER TYROSINE KINASE INHIBITORS IN THIRD-OR-LATER LINE CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Bosutinib; Medicine; Dasatinib; Nilotinib; Ponatinib; Internal medicine; Oncology; Population; Myeloid leukemia; Imatinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004148565,0.0006712619,0.00147678,0.0003841501,0.0001128714,0.00003101816,0.0003030099,0.0005064355,0.002669789],"category_scores_gemma":[0.0001795023,0.0005566317,0.0002855034,0.001704733,0.0002190372,0.0001929428,0.0002300637,0.000810782,0.0007883055],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006556749,"about_ca_system_score_gemma":0.002545922,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009713293,"about_ca_topic_score_gemma":0.004911879,"domain_scores_codex":[0.9958542,0.0001363247,0.001279624,0.0008730507,0.0008073415,0.001049459],"domain_scores_gemma":[0.9977313,0.0003535151,0.0004402187,0.001041044,0.0001125603,0.0003214081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.04454716,0.009844407,0.07331876,0.01402032,0.004511796,0.007245337,0.02245233,0.02026852,0.3501832,0.0004386531,0.1188706,0.334299],"study_design_scores_gemma":[0.2001754,0.01509951,0.02091477,0.008349274,0.001405076,0.000162894,0.003942523,0.03471164,0.6573765,0.0001021531,0.05540026,0.002360046],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891552,0.004716306,0.00001911842,0.000381627,0.0008415937,0.001333821,0.00007901888,0.0004718512,0.003001438],"genre_scores_gemma":[0.9918282,0.0003128352,0.000448094,0.00009040751,0.0007501257,0.0001397388,0.0003563192,0.0001944712,0.005879806],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3319389,"threshold_uncertainty_score":0.9999897,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05732872494174309,"score_gpt":0.3475958001907948,"score_spread":0.2902670752490517,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}